Related Experiment Videos
Genetic alterations associated with progression and recurrence in meningiomas
Elisa Pérez-Magán1, Yolanda Campos-Martín, Pilar Mur
1Molecular Pathology Research Unit, Virgen de la Salud Hospital, Toledo, Spain.
Journal of Neuropathology and Experimental Neurology
|September 12, 2012
Summary
Researchers identified a 49-gene signature predicting meningioma aggressiveness. Gene downregulation and hypermethylation may drive tumor progression and recurrence in these common brain tumors.
Area of Science:
- Neuro-oncology
- Molecular Biology
- Genetics
Background:
- Meningiomas are the most common primary brain tumors, typically benign but sometimes aggressive.
- Recurrence and aggressive histology indicate a need to understand meningioma progression.
- Genetic factors may underlie differences in meningioma behavior.
Purpose of the Study:
- To identify genetic features common to recurrent and aggressive meningiomas.
- To develop a gene expression signature for meningioma aggressivity.
Main Methods:
- Compared gene expression profiles of 128 meningioma samples (WHO Grades I, II, and III).
- Analyzed 121 patients' tumor samples for gene expression patterns related to progression and recurrence.
- Identified a 49-gene signature associated with tumor behavior.
Main Results:
- A 49-gene signature classified meningiomas into two groups with distinct clinical behaviors.
- The signature includes genes involved in cell cycle, WNT, and TGF-β pathways.
- Gene downregulation, potentially due to promoter hypermethylation (e.g., UCHL1, SFRP1), was observed in advanced/recurrent tumors.
Conclusions:
- A 49-gene signature can predict meningioma aggressivity and clinical behavior.
- Gene repression via hypermethylation and chromosomal changes may drive meningioma progression.
- Understanding these genetic and epigenetic alterations is crucial for managing meningioma recurrence.
Related Concept Videos
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
02:21Cancers Originate from Somatic Mutations in a Single Cell
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
02:23Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
01:20The Retinoblastoma Gene
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
01:20Mismatch Repair
Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...